At Tactiva Therapeutics, we are taking the fight to cancer by developing "Next Generation" adoptive cell therapy strategies that deliver lethal hits to cancer cells. Our approach provides robust and sustained immune attack on tumors by infusing large numbers of patients' own T cells that have been reprogramed to recognize, attack, and destroy cancer cells.